GENE ONLINE|News &
Opinion
Blog

Innovation
Trials & Approvals CRISPR
Intellia Trials CRISPR Drug as Permanent Cure to Fatal Hereditary Disease
2020-10-21
In-Depth CRISPR
CRISPR Technology in Disease Modelling and Drug Discovery
2020-10-21
Technology AI
Genentech Looks to Strengthen Drug Discovery by Collaborating With This Stanford Spinout
2020-10-21
R&D Aging
Insilico Medicine, Taisho Partnership Sets Precedent in Drug Discovery and Development
2020-10-18
IPO Codiak Biosciences
Cambridge Startup’s Take Two at Public Debut is Off to a Slow Start
2020-10-18
COVID-19 Spike Protein
Structural Study of SARS-CoV-2 Spike Protein Aids in Better Understanding of COVID-19 Infection
2020-10-18
In-Depth AAT
With its AAT Deficiency Therapy Biting the Dust, Vertex Pins Hope on Second Drug
2020-10-16
Technology AAV
Harvard Spinout Bags $1.8 Billion Worth Gene Therapy Deal with Roche
2020-10-15
Cystic Fibrosis
Ionis’ Inhaled Antisense Medicine Could Signal Decline for Cystic Fibrosis Medical Devices
2020-10-15
PI3K/AKT-Mediated Signaling Pathway
Two Clinical-Stage Biopharmas Enter Agreement to Develop Drug for Hematologic Malignancies
2020-10-14
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Technology 3D Printing
A.D.A.M’s Regulatory Progress Takes 3D Printed Bones a Step Closer to Reality
2020-10-11
In-Depth
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
R&D FGF-18
Merck Lets Go of Osteoarthritis Drug for €450 Million To Focus on Other Pipelines
2020-10-10
Trials & Approvals KRAS G12C Inhibitor
Amgen’s KRAS G12C Inhibitor Impresses in Phase 2 NSCLC Trial
2020-10-09
1 … 38 39 40 41 42 … 58
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top